Veeva Systems (VEEV) closed at $212.78 in the latest trading session, marking a +1.89% move from the prior day.
VEEV partners with Walgreens to provide better patient outcomes to life sciences companies.
Zacks.com users have recently been watching Veeva (VEEV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
VEEV's robust product portfolio raises optimism about the stock. However, escalating costs are concerning.
The latest trading day saw Veeva Systems (VEEV) settling at $212.23, representing a -0.18% change from its previous close.
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
The latest trading day saw Veeva Systems (VEEV) settling at $217.02, representing a -0.14% change from its previous close.
Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Veeva Systems (VEEV) reachead $210.13 at the closing of the latest trading day, reflecting a +1.59% change compared to its last close.
Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Veeva (VEEV) reported earnings 30 days ago. What's next for the stock?
Veeva Systems' addition of new capabilities is likely to improve the timeliness and accuracy of field actions to ensure product quality and patient safety.